JP2021100428A5 - - Google Patents

Download PDF

Info

Publication number
JP2021100428A5
JP2021100428A5 JP2021051049A JP2021051049A JP2021100428A5 JP 2021100428 A5 JP2021100428 A5 JP 2021100428A5 JP 2021051049 A JP2021051049 A JP 2021051049A JP 2021051049 A JP2021051049 A JP 2021051049A JP 2021100428 A5 JP2021100428 A5 JP 2021100428A5
Authority
JP
Japan
Prior art keywords
cell population
cells
kidney
isolated human
population
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021051049A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021100428A (ja
JP7685688B2 (ja
Filing date
Publication date
Priority claimed from JP2018094325A external-priority patent/JP2018148909A/ja
Application filed filed Critical
Publication of JP2021100428A publication Critical patent/JP2021100428A/ja
Priority to JP2023076983A priority Critical patent/JP7625287B2/ja
Publication of JP2021100428A5 publication Critical patent/JP2021100428A5/ja
Application granted granted Critical
Publication of JP7685688B2 publication Critical patent/JP7685688B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021051049A 2008-11-12 2021-03-25 単離した腎細胞およびその使用 Active JP7685688B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023076983A JP7625287B2 (ja) 2008-11-12 2023-05-09 単離した腎細胞およびその使用

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US11403008P 2008-11-12 2008-11-12
US11402508P 2008-11-12 2008-11-12
US61/114,030 2008-11-12
US61/114,025 2008-11-12
US20105608P 2008-12-05 2008-12-05
US61/201,056 2008-12-05
US20130508P 2008-12-08 2008-12-08
US61/201,305 2008-12-08
US12131108P 2008-12-10 2008-12-10
US61/121,311 2008-12-10
JP2018094325A JP2018148909A (ja) 2008-11-12 2018-05-16 単離した腎細胞およびその使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018094325A Division JP2018148909A (ja) 2008-11-12 2018-05-16 単離した腎細胞およびその使用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023076983A Division JP7625287B2 (ja) 2008-11-12 2023-05-09 単離した腎細胞およびその使用

Publications (3)

Publication Number Publication Date
JP2021100428A JP2021100428A (ja) 2021-07-08
JP2021100428A5 true JP2021100428A5 (https=) 2024-06-12
JP7685688B2 JP7685688B2 (ja) 2025-05-30

Family

ID=41625133

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2011535572A Active JP5974233B2 (ja) 2008-11-12 2009-11-12 単離した腎細胞およびその使用
JP2015164808A Withdrawn JP2016028578A (ja) 2008-11-12 2015-08-24 単離した腎細胞およびその使用
JP2018094325A Pending JP2018148909A (ja) 2008-11-12 2018-05-16 単離した腎細胞およびその使用
JP2021051049A Active JP7685688B2 (ja) 2008-11-12 2021-03-25 単離した腎細胞およびその使用
JP2023076983A Active JP7625287B2 (ja) 2008-11-12 2023-05-09 単離した腎細胞およびその使用

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2011535572A Active JP5974233B2 (ja) 2008-11-12 2009-11-12 単離した腎細胞およびその使用
JP2015164808A Withdrawn JP2016028578A (ja) 2008-11-12 2015-08-24 単離した腎細胞およびその使用
JP2018094325A Pending JP2018148909A (ja) 2008-11-12 2018-05-16 単離した腎細胞およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023076983A Active JP7625287B2 (ja) 2008-11-12 2023-05-09 単離した腎細胞およびその使用

Country Status (9)

Country Link
US (5) US8318484B2 (https=)
EP (3) EP2662440B1 (https=)
JP (5) JP5974233B2 (https=)
KR (6) KR102428795B1 (https=)
CN (2) CN103937737B (https=)
AU (5) AU2009314552B2 (https=)
CA (1) CA2743459A1 (https=)
NZ (2) NZ593207A (https=)
WO (1) WO2010056328A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101827933B (zh) 2007-06-08 2014-01-29 韦克福里斯特大学健康科学院 治疗肾功能衰竭的选择性细胞疗法
US10590391B2 (en) 2007-06-08 2020-03-17 Wake Forest University Health Sciences Selective cell therapy for the treatment of renal failure
KR102428795B1 (ko) * 2008-11-12 2022-08-04 인리젠 분리된 신장 세포 및 이의 용도
CA2780320A1 (en) 2009-11-12 2011-05-19 Tengion, Inc. Rational design of regenerative medicine products
TWI762890B (zh) 2010-05-12 2022-05-01 開曼群島商英瑞金公司 生物活性腎細胞
CA3065694A1 (en) * 2010-11-10 2012-05-18 Inregen Methods of forming injectable formulations for providing regenerative effects to an organ such as a kidney
ES2689265T3 (es) * 2011-11-04 2018-11-12 Inregen Cribado de fármacos y ensayos de potencia
RU2702721C2 (ru) * 2012-10-24 2019-10-09 инРиджен Популяции клеток почек и их применение
GB2516196B (en) * 2013-01-25 2015-09-09 Xcell Biosciences Inc Methods, compositions, kits, and systems for selective enrichment of target cells
EP4299721A3 (en) * 2013-05-08 2024-04-24 ProKidney Organoids comprising isolated renal cells and uses thereof
KR102771841B1 (ko) * 2015-11-06 2025-02-24 벤타나 메디컬 시스템즈, 인코포레이티드 대표 진단법
WO2018022108A1 (en) * 2016-07-29 2018-02-01 Deepak Jain Bioactive renal cells for the treatment of chronic kidney disease
US11123372B2 (en) 2016-07-29 2021-09-21 Prokidney Bioactive renal cells for the treatment of chronic kidney disease
BR112019027086A2 (pt) 2017-06-21 2020-07-07 Timothy A. Bertram células renais bioativas imunoprivilegiadas para o tratamento de doença renal
CN108251352B (zh) * 2018-02-01 2021-07-06 伯仕利生物科技发展（盐城）有限公司 一种血管内皮干细胞的培养方法
EP3843760A4 (en) 2018-08-31 2022-11-09 Timothy Bertram COMPOSITIONS WITH CELL-DERIVED VESICLES AND THEIR USES
WO2021177387A1 (ja) * 2020-03-04 2021-09-10 株式会社メトセラ エリスロポエチン産生能が亢進された線維芽細胞
WO2021176420A1 (en) 2020-03-06 2021-09-10 ReGenesys BVBA Biocompatible scaffolds for culturing post natal progenitor cells
CN112107600B (zh) * 2020-10-26 2024-04-05 张哲� 一种治疗色素沉着性疾病的纳米制剂及其制备方法
EP4243837A4 (en) * 2020-11-13 2025-01-15 Timothy A. Bertram ENRICHED BIOACTIVE KIDNEY CELL POPULATIONS, PROPERTIES AND USES THEREOF
CN114703120B (zh) * 2022-03-17 2024-02-02 上海纽仁生物医药科技有限公司 一种动物神经系统血管平滑肌细胞单细胞的分离方法
CN114507642B (zh) * 2022-03-17 2024-02-02 上海纽仁生物医药科技有限公司 一种动物神经系统周细胞单细胞的分离方法
US20250367238A1 (en) * 2022-06-29 2025-12-04 Pro Kidney Selected renal cell populations, characteristics and uses thereof
CN120869743B (zh) * 2025-09-29 2025-12-05 北京泛生子基因科技有限公司 一种用细胞系制备ffpe质控品的方法，参考品以及试剂盒

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6045849B2 (ja) * 1980-08-25 1985-10-12 林原 健 ヒトエリトロポエチンの製造方法
US5266480A (en) * 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
US5863531A (en) 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US5032508A (en) 1988-09-08 1991-07-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US4769037A (en) * 1986-10-28 1988-09-06 Midcalf Robert J Artificial replacement kidney implant and method of dialyzing blood
GB8722854D0 (en) * 1987-09-29 1987-11-04 Hardy S M Implantable artificial kidney
US5085629A (en) * 1988-10-06 1992-02-04 Medical Engineering Corporation Biodegradable stent
CN1053698C (zh) 1989-01-19 2000-06-21 南京大学 细胞培养生产促红细胞生成素的方法
DE69017820T2 (de) 1989-04-25 1995-10-05 Children's Medical Center Corp., Boston, Mass. Implantaten für grosse mengen von zellen auf polymerische matrizen.
US4996154A (en) * 1989-05-04 1991-02-26 Millipore Corporation Method for growing cellular tissue
AU2900792A (en) 1991-10-24 1993-05-21 Children's Medical Center Corporation Neomorphogenesis of urological structures in vivo from cell culture
NZ245015A (en) * 1991-11-05 1995-12-21 Transkaryotic Therapies Inc Delivery of human growth hormone through the administration of transfected cell lines encoding human growth hormone, which are physically protected from host immune response; the transfected cells and their production
US5549674A (en) * 1992-03-02 1996-08-27 The Regents Of The University Of Michigan Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
US6060270A (en) * 1992-03-02 2000-05-09 The University Of Michigan Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules
US6410320B1 (en) * 1992-03-02 2002-06-25 The University Of Michigan Method and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules
US5429938A (en) * 1992-03-02 1995-07-04 University Of Michigan Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules
US5545131A (en) * 1994-04-28 1996-08-13 White Eagle International Technologies, Lp Artificial kidney
US6673339B1 (en) * 1996-09-05 2004-01-06 Children's Medical Center Corporation Prosthetic kidney and its use for treating kidney disease
WO1998009582A1 (en) * 1996-09-05 1998-03-12 Children's Medical Center Corporation Prosthetic kidney and its use for treating kidney disease
US5952226A (en) * 1996-11-05 1999-09-14 Modex Therapeutiques Hypoxia responsive EPO producing cells
JP4235987B2 (ja) * 1996-12-19 2009-03-11 マグナチップセミコンダクター有限会社 ビデオフレームレンダリングエンジン
US5854006A (en) * 1997-03-28 1998-12-29 The University Of Virginia Gamma-glutamyl transpeptidase-specific antibody, prodrugs for the treatment of gamma-glutamyl transpeptidase-expressing tumors, and methods of administration thereof
US6946246B1 (en) * 1997-04-08 2005-09-20 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Production of functional proteins: balance of shear stress and gravity
US6224893B1 (en) 1997-04-11 2001-05-01 Massachusetts Institute Of Technology Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
JP2004155788A (ja) * 1998-09-24 2004-06-03 Tanabe Seiyaku Co Ltd 腎疾患治療薬およびそのスクリーニング方法
US6777205B1 (en) * 1998-11-06 2004-08-17 Sterrenbeld Biotechnologie North America, Inc. Host cells expressing recombinant human erythropoietin
US6747002B2 (en) * 1999-05-11 2004-06-08 Ortho-Mcneil Pharmaceutical, Inc. Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
US20040167634A1 (en) * 1999-05-26 2004-08-26 Anthony Atala Prosthetic kidney and its use for treating kidney disease
WO2000073791A1 (fr) 1999-05-27 2000-12-07 Tanabe Seiyaku Co., Ltd. Remedes pour affections renales et procede de criblage de tels medicaments
KR100369788B1 (ko) 1999-09-03 2003-01-29 동아제약 주식회사 재조합 인간 에리트로포이에틴의 제조방법
US6376244B1 (en) * 1999-12-29 2002-04-23 Children's Medical Center Corporation Methods and compositions for organ decellularization
US7326570B2 (en) * 2000-06-16 2008-02-05 The Regents Of The University Of California Induction of tubular morphogenesis using pleiotrophin
ATE392907T1 (de) * 2000-07-28 2008-05-15 Anika Therapeutics Inc Bioabsorbierbare kompositmaterialien aus derivatisierter hyaluronsäure
AU2002248237A1 (en) * 2000-10-30 2002-08-12 Zymogenetics, Inc. Compositions and methods for improving kidney function
WO2002061053A1 (en) 2001-01-31 2002-08-08 The General Hospital Corporation Renal stem cells and uses thereof
US20040152190A1 (en) * 2001-05-31 2004-08-05 Masaya Sumita Method of separating and concentrating cells for kidney regfneration
US6784154B2 (en) * 2001-11-01 2004-08-31 University Of Utah Research Foundation Method of use of erythropoietin to treat ischemic acute renal failure
BR0214217A (pt) * 2001-11-16 2004-09-21 Childrens Medical Center Aumento de função de órgão
US20030180268A1 (en) * 2002-02-05 2003-09-25 Anthony Atala Tissue engineered construct for supplementing or replacing a damaged organ
WO2003080038A1 (en) 2002-03-22 2003-10-02 Kissei Pharmaceutical Co., Ltd. Preventive or therapeutic agent for kidney disease
US8084424B2 (en) * 2003-04-09 2011-12-27 University Of Utah Research Foundation Compositions and methods related to erythropoietin
US20060153894A1 (en) * 2004-06-30 2006-07-13 Ragae Ghabrial Multi-compartment delivery system
WO2006055412A1 (en) * 2004-11-19 2006-05-26 Shiva Biomedical, Llc Methods of treating erythropoietin-resistance
WO2007035843A2 (en) 2005-09-21 2007-03-29 Dask Technologies, Llc Methods and compositions for organ and tissue functionality
US7850983B2 (en) * 2006-02-07 2010-12-14 Spinalcyte, Llc Methods and compositions for repair of cartilage using an in vivo bioreactor
CA2871840A1 (en) 2006-02-10 2007-08-23 Tengion, Inc. Scaffolds for organ reconstruction and augmentation
WO2007125916A1 (ja) * 2006-04-24 2007-11-08 Stemcell Institute Inc. 移植用臓器の調製方法
CN101595212B (zh) * 2006-10-12 2014-04-30 伊西康公司 肾源细胞及在组织修复和再生中的使用方法
AU2007319214B2 (en) 2006-11-16 2014-04-17 Genentech, Inc. Genetic variations associated with tumors
US20110008347A1 (en) 2006-12-01 2011-01-13 Agency For Science ,Technology And Research Cancer-related protein kinases
US9580688B2 (en) * 2007-06-08 2017-02-28 Wake Forest University Health Sciences Kidney structures and methods of forming the same
CN101827933B (zh) * 2007-06-08 2014-01-29 韦克福里斯特大学健康科学院 治疗肾功能衰竭的选择性细胞疗法
US10590391B2 (en) * 2007-06-08 2020-03-17 Wake Forest University Health Sciences Selective cell therapy for the treatment of renal failure
KR102428795B1 (ko) * 2008-11-12 2022-08-04 인리젠 분리된 신장 세포 및 이의 용도
JP5565607B2 (ja) 2009-07-15 2014-08-06 国立大学法人 東京大学 敗血症又は多臓器不全の予後診断方法及び予後診断用キット

Similar Documents

Publication Publication Date Title
JP2021100428A5 (https=)
Alatyyat et al. Umbilical cord stem cells: Background, processing and applications
Gökçinar-Yagci et al. Pericytes: properties, functions and applications in tissue engineering
EP1444329B1 (en) Stem cells that transform to beating cardiomyocytes
US20260053858A1 (en) Compositions comprising cell-delivered vesicles and uses thereof
KR101987395B1 (ko) Cd82 양성 심근 전구세포
CN105518126B (zh) 根据细胞尺寸来培养间充质干细胞的方法
Sanchez et al. Characterization of tunneling nanotubes in Wharton’s jelly mesenchymal stem cells. An intercellular exchange of components between neighboring cells
WO2007024441A2 (en) Compositions of cells enriched for combinations of various stem and progenitor cell populations, methods of use thereof and methods of private banking thereof
JP2020531028A (ja) ニューロピリン−１（ｎｒｐ１）のヒト心室前駆細胞を単離するための細胞表面マーカーとしての使用
Manikowski et al. Human adipose tissue-derived stromal cells in combination with exogenous stimuli facilitate three-dimensional network formation of human endothelial cells derived from various sources
JP2020512406A5 (https=)
CN108699520A (zh) 细胞块、细胞结构体以及立体组织体
Daneker et al. Culture and characterization of sinusoidal endothelial cells isolated from human liver
CN103459590A (zh) 可由机体的脐带或脂肪组织分离的多能干细胞
Kusuma et al. Derivation and network formation of vascular cells from human pluripotent stem cells
EP3911339B1 (en) Platelet rich-fibrin derived mesenchymal stem cells
JP7773294B2 (ja) 拡張型心筋症治療剤
JP6670040B2 (ja) シート状細胞培養物の製造方法
WO2017131241A1 (ja) 細胞塊、細胞構造体及び立体組織体
EP4569089A1 (en) Methods for hematopoietic stem and progenitor cell expansion and differentiation in three-dimensional silk scaffolds and uses thereof
BR112020004517A2 (pt) células tronco derivadas de porco neonato e processo para sua preparação
Thiel et al. Efficient transfection of primary cells relevant for cardiovascular research by nucleofection®
CN111603482A (zh) 一种用于免疫功能调节的间充质干细胞药物及制备方法
JP2017176025A (ja) 三次元細胞培養物の製造方法